Recherche
-
Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro
(Journal of Experimental Orthopaedics. vol. 5, n° 1, pp. 47, 2018-10)Article de revueLibre accès -
État actuel de l’utilisation en essais cliniques de molécules radiomarquées au 68Ga en France. Exemple du site de Bordeaux
(Médecine Nucléaire. vol. 42(6), pp. 428–431, 2018)Article de revue -
Targeting Pdzrn3 maintains adult blood-brain barrier and central nervous system homeostasis
(Journal of Cerebral Blood Flow and Metabolism. pp. 271678X211048981, 2021-10-13)Article de revueLibre accès -
Covichem: A biochemical severity risk score of COVID-19 upon hospital admission
(PLoS ONE. vol. 16, n° 5, pp. e0250956, 2021-04-17)Article de revueLibre accès -
Five-Year Symptom Trajectories in Nondialysis-Dependent CKD Patients.
(Clinical Journal of the American Society of Nephrology. vol. 17, n° 11, pp. 1588-1597, 2022-11-01)Article de revue -
A plea for renin-angiotensin system blockers as first-line treatment in cases of severe acute hypertension.
(Nephrology Dialysis Transplantation, 2020-12-25)Article de revueLibre accès -
Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID-19 disease
(Journal of Translational Medicine. vol. 22, n° 1, pp. 246, 2024-03-07)Article de revueLibre accès -
Balance between neutrophil extracellular trap formation and DNase activity in COVID-19 patients: a prospective cohort study
Communication dans un congrès -
Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients
(Frontiers in Immunology. vol. 13, 2022-03-17)Article de revueLibre accès -
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
(Clinical Microbiology and Infection. vol. 28, n° 7, pp. 1010-1016, 2022-07-01)Article de revueLibre accès